Shaanxi Kanghui Pharm Co Ltd (603139) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.010x

Based on the latest financial reports, Shaanxi Kanghui Pharm Co Ltd (603139) has a cash flow conversion efficiency ratio of 0.010x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥7.14 Million ≈ $1.04 Million USD) by net assets (CN¥745.41 Million ≈ $109.08 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Shaanxi Kanghui Pharm Co Ltd (603139) net asset quality to measure how much of total assets are equity-financed.

Shaanxi Kanghui Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Shaanxi Kanghui Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 603139 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Shaanxi Kanghui Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shaanxi Kanghui Pharm Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Sella Real Estate TA:SLARL	0.021x
Guangdong Sunwill Precising Plastic Co Ltd SHE:002676	0.061x
Ningxia Qinglong Pipes Industry Co Ltd SHE:002457	0.044x
Newtechwood Corp SHE:301588	N/A
Gigalane Co Ltd KQ:049080	-0.089x
JL MAG RARE-EARTH H YC1 F:3KLA	N/A
Avax S.A AT:AVAX	0.076x
Shanghai Metersbonwe Fashion&Accessories Co Ltd SHE:002269	-0.519x

Annual Cash Flow Conversion Efficiency for Shaanxi Kanghui Pharm Co Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Shaanxi Kanghui Pharm Co Ltd from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see 603139 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥568.98 Million ≈ $83.26 Million	CN¥-16.72 Million ≈ $-2.45 Million	-0.029x	-171.46%
2024-12-31	CN¥906.90 Million ≈ $132.71 Million	CN¥37.29 Million ≈ $5.46 Million	0.041x	+158.14%
2023-12-31	CN¥1.02 Billion ≈ $149.25 Million	CN¥-72.13 Million ≈ $-10.56 Million	-0.071x	-243.87%
2022-12-31	CN¥1.03 Billion ≈ $150.13 Million	CN¥50.43 Million ≈ $7.38 Million	0.049x	+638.84%
2021-12-31	CN¥1.12 Billion ≈ $163.16 Million	CN¥7.42 Million ≈ $1.09 Million	0.007x	-92.38%
2020-12-31	CN¥1.07 Billion ≈ $157.00 Million	CN¥93.72 Million ≈ $13.71 Million	0.087x	-17.40%
2019-12-31	CN¥1.02 Billion ≈ $148.79 Million	CN¥107.53 Million ≈ $15.73 Million	0.106x	+65.34%
2018-12-31	CN¥979.31 Million ≈ $143.30 Million	CN¥62.64 Million ≈ $9.17 Million	0.064x	+33.81%
2017-12-31	CN¥912.11 Million ≈ $133.47 Million	CN¥43.60 Million ≈ $6.38 Million	0.048x	-65.16%
2016-12-31	CN¥522.81 Million ≈ $76.50 Million	CN¥71.72 Million ≈ $10.49 Million	0.137x	+120.22%
2015-12-31	CN¥457.58 Million ≈ $66.96 Million	CN¥28.50 Million ≈ $4.17 Million	0.062x	+8.38%
2014-12-31	CN¥395.37 Million ≈ $57.86 Million	CN¥22.72 Million ≈ $3.33 Million	0.057x	-51.42%
2013-12-31	CN¥332.63 Million ≈ $48.67 Million	CN¥39.35 Million ≈ $5.76 Million	0.118x	+54.43%
2012-12-31	CN¥210.43 Million ≈ $30.79 Million	CN¥16.12 Million ≈ $2.36 Million	0.077x	--

About Shaanxi Kanghui Pharm Co Ltd

SHG:603139 China Drug Manufacturers - Specialty & Generic

Market Cap

$529.81 Million

CN¥3.62 Billion CNY

Market Cap Rank

#11900 Global

#3405 in China

Share Price

CN¥36.25

Change (1 day)

+3.78%

52-Week Range

CN¥20.27 - CN¥45.21

All Time High

CN¥45.21